OakChart

Healthcare Triangle Inc

HCTIHealthcare·Health Information Services·USA·Nano·NASD·Nov 11 • 3:59 PM ET

4.39+0.18 (4.28%)
2026-11-12 02:10 CET
Market cap
3.89 USD m
Revenue, TTM
25.68 USD m
Net income, TTM
-17.02 USD m
Free cash flow, TTM
-25.42 USD m
EPS diluted, TTM
-1,311.70
P/E
-
Compare

Price

HCTI against its 20, 50 and 200-day averages
2050200earnings
0.00500.001,000.001,500.002,000.001.4M2.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HCTIclose 4.3920-day 6.0350-day 10.69200-day 50.594.39

99.9% under the 52-week high of 3,252.00 on 11 Nov 2025. 52-week low 3.51 on 5 Nov 2026. Last 15 sessions, 132.6% high to low

Volume 0.14× normal · the line is the 50-bar volume average

Profile

HCTI
52-week range, 0% of the way up
3.513,252

Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded by Suresh Venkatachari and Keith T. Ryan on October 29, 2019 and is headquartered in Pleasanton, CA.

Employees84
IPOOct 13, 2021
Beta1.19
ATR, 14d1.25
Rel volume0.14
Short float15.62%
Inst own1.15%

Snapshot

6 groups

Valuation

Index-
Market Cap3.89M
Enterprise Value40.32M
Income-17.02M
Sales25.68M
Book/sh234.28
Cash/sh2.16
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees84
IPOOct 13, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S0.15
P/B0.02
P/C2.04
P/FCF-
EV/EBITDA-
EV/Sales1.57
Quick Ratio0.60
Current Ratio0.60
Debt/Eq0.26
LT Debt/Eq0.07
Option/ShortNo / Yes

Earnings

EPS (ttm)-1311.70
EPS next Y-63.60
EPS next Q-19.40
EPS this Y77.05%
EPS next Y68.91%
EPS next 5Y-
EPS past 3/5Y86.18% -
Sales past 3/5Y-32.85% -15.02%
EPS Y/Y TTM99.31%
Sales Y/Y TTM116.40%
EPS Q/Q95.50%
Sales Q/Q158.38%
EarningsAug 13 BMO
EPS/Sales Surpr.54.52% -11.16%

Ownership

Insider Own-
Insider Trans-
Inst Own1.15%
Inst Trans-
ROA-38.60%
ROE-57.32%
ROIC-32.36%
Gross Margin13.61%
Oper. Margin-57.36%
Profit Margin-66.30%
SMA20-27.15%
SMA50-58.92%
SMA200-91.32%
Trades-

Technical

Shs Outstand0.89M
Shs Float0.12M
Short Float15.62%
Short Ratio0.14
Short Interest0.02M
52W High3252.00 -99.87%
52W Low3.51 25.07%
Volatility13.60% 14.75%
ATR (14)1.25
RSI (14)29.50
Beta1.19
Rel Volume0.14
Avg Volume137.82K
Volume18,787

Performance

Perf Week-4.98%
Perf Month-47.54%
Perf Quarter-87.31%
Perf Half Y-89.98%
Perf YTD-99.42%
Perf Year-99.86%
Perf 3Y-100.00%
Perf 5Y-100.00%
Perf 10Y-
Recom-
Target Price63.00
Prev Close4.21
Price4.39
Change %4.28%

Peers

Mkt cap
TickerCompanyMkt cap
CCLDCareCloud Inc112.75M
HCATHealth Catalyst Inc108.90M
DHDefinitive Healthcare Corp185.93M
ONMDOneMedNet Corp32.28M
WAYWaystar Holding Corp5.55B
SPOKSpok Holdings Inc247.81M
CTEVClaritev Corp481.68M
HSTMHealthstream Inc884.68M
VEEVVeeva Systems Inc49.34B
MHHMastech Digital Inc74.70M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 198
  • Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity (PR Newswire)
  • Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia (PR Newswire)
  • Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum Builds (PR Newswire) -8.80%
  • Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan (PR Newswire) +5.33%
  • HCTI Expands AI Business with 6 New Contracts, Targeting approx. $4.65M in Annual Run Rate Revenue (PR Newswire) +8.12%
  • Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America (PR Newswire) +8.48%
  • Healthcare Triangle Signs LOI for Proposed Roboticom Acquisition in $30 Million Deal (InvestorsHub) +5.37%
  • Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business (PR Newswire)
  • Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies (PR Newswire)
  • Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing. (PR Newswire)
  • Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026 (PR Newswire) +39.52%
  • HCTI's Teyame Delivers a Full Year of Client Revenue in Six Months; 2 Million in Target (PR Newswire) +10.19%
  • Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets (PR Newswire) -26.60%
  • Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-13-31.200-68.600-376,4889.1910.351
2026Q12026-05-12-136.8--133.199.86--
2025Q42026-03-13-1.400--632.343.14--
2023Q42024-03-15-376,488--116,4337.10--
2023Q32023-11-13-552--137,3057.80--
2023Q22023-08-10-504--126,2078.50--
2023Q12023-05-09-96.000--233,9909.80--
2022Q42023-03-28-156--348,37111.30-1
2022Q32022-11-11-84.000-48.000-194,01111.9512.601
2022Q22022-08-08-12.000-60.000-34,09311.5911.701
2022Q12022-05-17-72.000-60.000-169,24011.1010.401
2021Q42022-03-08-144--292,0479.20--
2021Q32022-01-19-60.000--169,1818.08--
2026Q3---19.400--9.651
2026Q4---17.400--10.141

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-2,4003,720-604,14435.2040.00
2022FY-3,120-2,400-1,159,97145.8047.00
2023FY-872,496--621,03233.20-
2025FY-891.6--872,49613.89-
2026FY--204.6--38.84
2027FY--63.600--40.54

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-271009.659.659.65
2026Q3S2026-08-131019.659.659.65
2026Q3S2026-05-1310010.8710.8710.87
2026Q3E2026-10-27100-19.40-19.40-19.40
2026Q3E2026-08-13101-19.40-19.40-19.40
2026Q3E2026-07-28110-4.80-4.80-4.80
2026Q3E2026-05-13100-61.80-61.80-61.80
2026Q2S2026-05-1310010.3510.3510.35
2026Q2E2026-05-13100-3.43-3.43-3.43
2026Q1S2026-05-131009.869.869.86
2026Q1E2026-05-13100-6.84-6.84-6.84
2026FYS2026-10-2710038.8438.8438.84
2026FYS2026-08-1310138.8438.8438.84
2026FYS2026-07-2710042.4842.4842.48

Estimate history

EPS, annual99530.28199867.32-604143.721-1159971.481-621031.897-337900.968-3063.108-1311.6994
Period2019202020212022202320242025TTM
EPS, quarterly-84868.164-65864.484-71078.544-51602.76-699.192-514.692-632.34-133.194-31.473
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual28.73731.33935.2745.88633.20311.69613.89125.68
Period2019202020212022202320242025TTM
Sales, quarterly2.9842.4132.193.7043.5583.4893.1399.8559.193
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0000000.0070.101
Period2019202020212022202320242025MRQ
Shares, quarterly00000.0050.0040.0070.0920.101
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue25.6813.8911.7033.2045.8935.2731.3428.74
Cost of Goods Sold Incl. D&A22.1812.719.7027.9937.5326.1723.5623.66
Gross Profit3.491.192.005.218.359.107.785.07
Selling, General and Administrative Excl. Other18.1810.976.7511.2020.3114.466.613.40
Research and Development0.470.540.430.808.145.261.741.01
Other Operating Expense0.040.000.000.000.000.000.000.00
Operating Income-14.73-9.79-4.75-5.99-11.96-5.361.181.67
Interest Expense0.310.571.210.970.210.570.080.05
Unusual Expense3.05-0.04-0.011.711.680.00-1.510.00
Net Income Before Taxes-17.00-9.48-5.96-8.65-13.85-5.932.611.62
Income Taxes0.020.000.010.040.510.020.260.44
Consolidated Net Income-17.02-9.48-5.97-8.69-14.36-5.952.351.17
Net Income From Continuing Operations-17.02-9.48-5.97-8.69-14.36-5.952.351.17
Net Income-17.02-9.48-5.97-8.69-14.36-5.952.351.17
EPS (Recurring)-106.15-3,072.39-338,177.76-535,448.34-1,064,781.71-604,144.92109,936.0599,541.58
EPS (Basic, Before Extraordinaries)-1,311.70-3,063.11-337,900.97-621,031.90-1,159,971.48-604,143.72199,867.3299,530.28
EPS (Diluted)-1,311.70-3,063.11-337,900.97-621,031.90-1,159,971.48-604,143.72199,867.3299,530.28
EBITDA-12.70-9.08-3.86-4.42-9.02-3.941.982.45
Non-Operating Income (Expense)1.080.840.000.010.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.450.070.130.200.04--
Price To Sales Ratio0.200.170.450.350.141.51--
Gross Margin13.618.5317.1115.6918.2025.8024.8317.65
Operating Margin-57.36-70.47-40.62-18.03-26.06-15.193.755.81
Net Margin-66.30-68.22-51.03-26.16-31.29-16.877.514.08
Shares Outstanding0.100.010.000.000.000.000.000.00
Market Capitalization3.893.895.5911.747.0963.8263.86-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue9.199.863.143.493.563.702.192.41
Cost of Goods Sold Incl. D&A7.668.273.322.933.063.391.932.03
Gross Profit1.541.58-0.180.560.490.320.260.38
Selling, General and Administrative Excl. Other5.615.214.223.151.851.721.111.55
Research and Development0.050.090.280.060.060.14-0.17
Other Operating Expense0.000.000.040.000.000.000.000.00
Operating Income-4.07-3.62-4.44-2.59-1.36-1.40-0.85-1.17
Interest Expense0.090.090.100.030.020.410.850.08
Unusual Expense0.652.44-0.040.000.000.000.000.00
Net Income Before Taxes-4.39-6.20-4.50-1.91-1.37-1.70-1.34-1.25
Income Taxes0.020.000.000.000.000.000.000.00
Consolidated Net Income-4.42-6.20-4.50-1.91-1.37-1.70-1.35-1.25
Net Income From Continuing Operations-4.42-6.20-4.50-1.91-1.37-1.70-1.35-1.25
Net Income-4.42-6.20-4.50-1.91-1.37-1.70-1.35-1.25
EPS (Recurring)-28.22-96.56-636.37-514.70-700.51-51,601.92-71,077.81-65,864.03
EPS (Basic, Before Extraordinaries)-31.47-133.19-632.34-514.69-699.19-51,602.76-71,078.54-65,864.48
EPS (Diluted)-31.47-133.19-632.34-514.69-699.19-51,602.76-71,078.54-65,864.48
EBITDA-3.54-2.81-3.81-2.53-1.36-1.39-1.00-0.82
Non-Operating Income (Expense)0.42-0.06-0.000.720.010.110.010.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense---0.000.000.000.04-0.06
Price To Sales Ratio0.200.120.390.901.370.260.480.17
Gross Margin16.7316.06-5.8015.9113.888.5611.6915.71
Operating Margin-44.28-36.76-141.54-74.26-38.20-37.74-38.90-48.36
Net Margin-48.03-62.89-143.45-54.63-38.45-45.90-61.55-51.76
Shares Outstanding0.100.090.010.000.000.000.000.00
Market Capitalization3.894.975.4111.6940.374.815.592.78

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments7.620.021.231.341.771.400.97
Short Term Receivables2.071.113.605.879.676.404.17
Inventories0.000.000.000.000.000.000.00
Other Current Assets3.460.320.820.820.360.230.15
Total Current Assets13.151.455.658.0211.808.035.29
Net Property, Plant & Equipment0.010.010.040.080.250.020.04
Total Investments and Advances0.000.000.000.000.000.000.00
Long-Term Note Receivable3.830.500.301.070.820.450.00
Intangible Assets5.750.000.864.0811.752.622.92
Deferred Tax Assets3.87------
Other Assets0.000.000.000.000.000.000.00
Total Assets26.601.966.8613.2624.6111.118.25
Short Term Debt Incl. Current Port. of LT Debt10.742.653.792.692.380.750.00
Accounts Payable0.742.541.951.481.874.355.10
Other Current Liabilities1.311.891.912.431.991.681.10
Total Current Liabilities12.797.087.656.606.256.786.20
Long Term Debt0.000.000.100.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities3.87------
Other Liabilities0.000.000.500.622.230.000.08
Total Liabilities16.667.088.257.228.486.786.28
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value7.437.430.000.001E-060.000.00
Common Equity2.55-12.55-1.396.0416.134.331.97
Total Shareholders Equity9.98-5.11-1.396.0416.134.331.97
Accumulated Minority Interest-0.040.000.000.000.000.000.00
Total Equity9.94-5.11-1.396.0416.134.331.97
Total Liabilities & Stockholders Equity26.601.966.8613.2624.6111.118.25
Book Value Per Share357.53-661,688.04-96,460.42432,695.361,367,269.43367,585.45167,720.05
Tangible Book Value Per Share-450.49-661,688.06-155,890.05140,052.91371,873.63145,161.25-80,188.09
Full-Time Employees846033517769-
Price to Book Ratio0.02-0.451.920.403.9623.58-
Return on Assets-66.35-135.37-62.89-75.82-33.3124.31-
Return on Equity-389.40--157.97-129.50-58.1574.67-
Return on Invested Capital-94.94---237.72-36.8854.3759.35
Quick Ratio1.030.210.741.221.891.180.85
Current Ratio1.030.210.741.221.891.180.85

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-17.02-9.48-5.97-8.69-14.36-5.952.351.17
Depreciation2.030.700.891.572.941.420.800.78
Other Funds (Non Cash)4.220.371.311.972.311.370.000.00
Funds from Operations-10.78-8.40-3.77-5.15-9.10-3.163.161.95
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-5.99-8.692.693.003.75-4.13-3.892.02
Cash from Operating Activities-16.77-17.09-1.08-2.15-5.35-7.29-0.733.97
Capital Expenditures-8.65-1.500.00-0.01-1.13-3.13-0.48-3.65
Net Assets From Acquisitions0.000.000.000.000.00-4.500.000.00
Sale of Fixed Assets and Businesses0.010.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses-0.25-0.250.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-10.39-1.750.00-0.01-1.13-7.63-0.48-3.65
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock12.7717.030.000.505.780.000.000.00
Repurchase of Common Pref Stock0.000.000.000.00-0.140.000.000.00
Sale of Common Pref Stock12.7717.030.000.505.920.000.000.00
Proceedsfrom Stock Options12.7717.030.000.505.890.000.000.00
Issuance or Reduction of Debt, Net13.039.41-0.131.560.485E-051.640.00
Change in Long Term Debt0.000.000.960.000.005E-050.000.00
Issuance of Long Term Debt0.000.000.960.000.005E-050.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.0015.290.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities25.8026.45-0.132.066.0615.291.640.00
Net Change in Cash-1.327.61-1.21-0.11-0.430.370.430.32
Free Cash Flow-25.42-17.10-1.08-2.16-5.39-7.37-0.733.97
Preferred Dividends (Cash Flow)---0.000.00-0.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.914.327.621.633.236.83
Short Term Receivables7.079.822.075.945.482.73
Inventories0.000.000.000.000.000.00
Other Current Assets0.564.763.460.370.160.28
Total Current Assets9.5318.8913.157.948.879.84
Net Property, Plant & Equipment2.382.500.010.010.000.00
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets57.7758.165.755.895.700.00
Deferred Tax Assets0.380.403.87---
Other Assets0.310.200.000.000.000.00
Total Assets73.6480.1626.6013.8414.5711.79
Short Term Debt Incl. Current Port. of LT Debt9.599.5410.741.530.410.78
Accounts Payable1.203.290.741.312.071.62
Other Current Liabilities5.208.161.311.070.670.81
Total Current Liabilities15.9920.9912.793.913.163.21
Long Term Debt3.411.330.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--3.87---
Other Liabilities5.145.140.001.201.200.00
Total Liabilities24.5427.4616.665.114.363.21
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value25.4325.437.437.437.437.43
Common Equity23.7527.322.551.312.771.14
Total Shareholders Equity49.1952.769.988.7410.218.58
Accumulated Minority Interest-0.09-0.06-0.04-0.020.000.00
Total Equity49.1052.709.948.7310.218.58
Total Liabilities & Stockholders Equity73.6480.1626.6013.8414.5711.79
Book Value Per Share234.28295.96357.53353.48570.7921,275.82
Tangible Book Value Per Share-335.53-334.07-450.49-1,237.32-602.0721,275.82
Full-Time Employees-418491--
Price to Book Ratio0.020.182.128.9314.554.21
Return on Assets-38.60-30.40-66.36-67.96-55.03-62.25
Return on Equity-57.32-45.57-389.44-182.56-118.48-143.99
Return on Invested Capital-8.39-11.46-45.12-21.80-13.40-19.82
Quick Ratio0.600.901.032.032.813.07
Current Ratio0.600.901.032.032.813.07

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-4.42-6.20-4.50-1.91-1.37-1.70
Depreciation0.530.810.630.060.000.01
Other Funds (Non Cash)1.822.57-0.01-0.16-0.010.55
Funds from Operations-2.07-2.82-3.88-2.00-1.38-1.14
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.15-4.12-3.050.03-1.25-4.42
Cash from Operating Activities-0.92-6.95-6.93-1.96-2.63-5.56
Capital Expenditures-3.23-6.02-0.21-0.69-0.600.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.010.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.00-0.250.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-3.22-6.02-0.46-0.69-0.600.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.548.882.730.630.0013.68
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.548.882.730.630.0013.68
Proceedsfrom Stock Options0.548.882.730.630.0013.68
Issuance or Reduction of Debt, Net1.130.8210.660.42-0.36-1.31
Change in Long Term Debt-0.270.270.000.000.000.00
Issuance of Long Term Debt-0.270.270.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.14-0.140.000.000.000.00
Other Financing Activities Uses0.14-0.140.000.000.000.00
Cash from Financing Activities1.809.5613.391.05-0.3612.36
Exchange Rate Effect-0.070.10----
Net Change in Cash-2.41-3.316.00-1.60-3.606.81
Free Cash Flow-4.15-12.97-5.65-2.65-3.24-5.56

Revenue breakdown

Corporate Others2024: 288.00K 2025: 278.00K
Managed Services And Support2024: 6.72M 2025: 5.36M
Software Services2024: 4.69M 2025: 8.26M
United States2024: 11.70M 2025: 13.89M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.63%0.0M0.1M115.50K
2026-10-1510.36%0.0M0.1M113.43K
2026-09-305.17%0.0M0.7M113.14K
2026-09-153.24%0.0M0.7M50.84K
2026-08-312.47%0.0M0.7M47.69K
2026-08-143.76%0.0M0.7M46.84K
2026-07-318.68%0.0M0.1M11.20K
2026-07-157.83%0.0M0.1M11.15K
2026-06-308.93%0.0M0.1M13.89K
2026-06-152.70%0.0M0.1M18.45K
2026-05-294.84%0.0M0.1M20.46K
2026-05-1519.96%0.0M0.1M36.45K
2026-04-308.96%0.0M0.1M34.61K
2026-04-1510.17%0.0M0.1M40.16K
2026-03-3122.35%0.0M0.1M35.88K
2026-03-138.85%0.0M0.1M27.28K
2026-02-2761.60%0.0M0.1M24.77K
2026-02-1325.54%0.0M0.0M7.99K
2026-01-3042.44%0.0M0.0M6.61K
2026-01-152.03%0.0M0.0M465

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-278-KCurrent report2026-10-26SEC
2026-10-238-KCurrent report2026-10-23SEC
2026-10-13DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-23SEC
2026-10-02PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-02SEC
2026-10-028-KCurrent report2026-10-01SEC
2026-09-30EFFECTEffectiveness filing by commission orderSEC
2026-09-25POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC
2026-09-258-KCurrent report2026-09-22SEC
2026-09-088-KCurrent report2026-09-02SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-28SEC
2026-07-208-KCurrent report2026-07-17SEC
2026-07-16424B3SEC
2026-07-15EFFECTEffectiveness filing by commission orderSEC
2026-07-10S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-07-09RWRegistration Withdrawal RequestSEC
2026-07-06S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-06-26DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-07-17SEC
2026-06-268-KCurrent report2026-06-24SEC
2026-06-16PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-16SEC
2026-06-16DNotice of sales of securities on Form D (Regulation D)SEC
2026-06-158-KCurrent report2026-06-12SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-1610-K/A2025-12-31SEC
2026-04-1510-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-04-108-KCurrent report2026-04-07SEC
2026-04-078-K/A2026-01-22SEC
2026-03-31NT 10-K2025-12-31SEC
2026-03-31424B5SEC
2026-03-118-KCurrent report2026-03-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
UBS Group AG0.77%
GEODE CAPITAL MANAGEMENT, LLC0.45%
BANK OF MONTREAL /CAN/0.13%
Tower Research Capital LLC0.06%
VANGUARD CAPITAL MANAGEMENT LLC0.04%
BARCLAYS PLC0.02%
JPMORGAN CHASE & CO0.00%
DANSKE BANK A/S0.00%

Funds

Fund% owned
Invesco BuyBack AchieversTM ETF0.08%
Fidelity Extended Market Index Fund0.07%
VANGUARD EXTENDED MARKET INDEX FUND0.04%
Fidelity Series Total Market Index Fund0.01%
Fidelity Nasdaq Composite Index Fund0.00%
Fidelity Total Market Index Fund0.00%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. HCTI. Cached 15 minutes.

Some panels did not load: ratings, insider.